MIRATI THERAPEUTICS INC shareholders Q3 2023

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.

MIRATI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Clearline Capital LP 51,275$2,233,5390.19%
PIER 88 INVESTMENT PARTNERS LLC 16,440$716,1260.18%
Campbell & CO Investment Adviser LLC 31,587$1,375,9300.16%
ALGERT GLOBAL LLC 74,286$3,2360.15%
Fiera Capital Corp 1,038,836$45,251,6960.14%
Woodline Partners LP 278,223$12,119,3940.14%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,175,000$51,183,0000.12%
Verition Fund Management LLC 206,479$8,994,2250.10%
PROFUND ADVISORS LLC 41,039$1,787,6590.10%
Orbimed Advisors 100,000$4,356,0000.09%
MOORE CAPITAL MANAGEMENT, LP 100,000$4,356,0000.08%
Virtus ETF Advisers LLC 2,684$116,9150.07%
UBS OCONNOR LLC 64,698$2,818,2450.07%
BALYASNY ASSET MANAGEMENT L.P. 775,747$33,791,5390.07%
Leucadia National 173,665$7,564,8470.07%
Jump Financial, LLC 40,667$1,771,4550.07%
Rafferty Asset Management, LLC 249,612$10,873,0990.06%
Hennion & Walsh Asset Management, Inc. 22,536$981,6680.06%
Caption Management, LLC 82,100$3,576,2760.06%
NWI MANAGEMENT LP 25,000$1,0890.05%
External links

This page lists MIRATI THERAPEUTICS INC's shareholders in Q3 2023. To view MIRATI THERAPEUTICS INC's shareholder history, click here.